结合最小侵入性中枢置换与脏移植:一个开创性的案例
Abudar Al Ganadi1, Ismail Al-Shameri2, Nabeel Mughallis2
1Cardiovascular and Kidney Transplantation Center, Faculty of Medicine, Taiz University, Taiz, Yemen.
The American journal of case reports
|November 27, 2025
概括
这项研究表明,对于高风险患者来说,将最少的侵入性 mitra 置换与脏移植相结合是可行的. 这种单次治疗方法减少了外科手术的负担,并有助于早期恢复.
科学领域:
- 心脏病学 心脏病学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 手术创新 在外科创新.
背景情况:
- 心脏膜疾病是接受脏移植患者的重要危险因素.
- 末期病患者中中枢病理增加了手术风险,并影响了移植结果.
- 对这些疾病的传统分阶段程序增加了患者的负担.
研究的目的:
- 描述一种新的联合手术方法,用于同时进行中枢置换和脏移植.
- 评估与脏移植相结合的微创心脏手术的可行性和结果.
主要方法:
- 一名42岁的男性患有末期脏病和严重的部吐,同时接受了手术.
- 副心置换是通过右侧小胸口切除术与外围心肺旁路术进行的.
- 接下来是开放的腹膜外活体捐赠者移植.
主要成果:
- 患者经历了无事件的恢复,功能正常化,假体门性能良好.
- 微创心脏治疗方法导致出血减少,没有胸部并发症或输血.
- 这是首次报告的同时进行微创性 mitra 置换和脏移植的病例.
结论:
- 同时进行关节置换和脏移植是被选中高风险患者的可行选择.
- 综合方法可以减少麻醉剂的暴露,加快恢复.
- 这一策略可以减少移植的延迟,并改善患者的治疗结果.
相关概念视频
Mitral Stenosis III: Medical Management
223
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
223
Mitral Regurgitation III: Medical Management
257
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
257
Kidney Transplant I: Introduction
310
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
310
Kidney Transplant II: Surgical Procedure
289
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
289
Mitral Valve Prolapse II: Assessment and Management
385
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
385
Mitral Stenosis I: Introduction
398
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
398


